{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:48:57Z","timestamp":1793947737476,"version":"4.8.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology of Taiwan","doi-asserted-by":"crossref","award":["MOST 110-2314-B-A49A-541-MY3"],"award-info":[{"award-number":["MOST 110-2314-B-A49A-541-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"name":"TVGH","award":["C19-027"],"award-info":[{"award-number":["C19-027"]}]},{"name":"TVGH and NTUH","award":["VN111-05"],"award-info":[{"award-number":["VN111-05"]}]},{"DOI":"10.13039\/501100017231","name":"Research Foundation of Cardiovascular Medicine","doi-asserted-by":"publisher","award":["110-02-006"],"award-info":[{"award-number":["110-02-006"]}],"id":[{"id":"10.13039\/501100017231","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02552-3","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T09:25:36Z","timestamp":1744277136000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Long-term trajectories of apolipoprotein A1 and major adverse cardiovascular events and mortality in a community cohort"],"prefix":"10.1186","volume":"24","author":[{"given":"Yang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Liong","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yenn-Jiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cheng","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Ann","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"issue":"25","key":"2552_CR1","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol. 2020;76(25):2982\u20133021.","journal-title":"J Am Coll Cardiol"},{"key":"2552_CR2","doi-asserted-by":"crossref","unstructured":"Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, Kueh MTW et al. Global burden of cardiovascular diseases: projections from 2025 to 2050. Eur J Prev Cardiol. 2024;zwae281.","DOI":"10.1093\/eurjpc\/zwae281"},{"key":"2552_CR3","volume-title":"Forecasting the burden of cardiovascular disease and stroke in the united States through 2050-Prevalence of risk factors and disease","author":"KE Joynt Maddox","year":"2024","unstructured":"Joynt Maddox KE, Elkind MSV, Aparicio HJ, Commodore-Mensah Y, de Ferranti SD, Dowd WN, et al. Forecasting the burden of cardiovascular disease and stroke in the united States through 2050-Prevalence of risk factors and disease. Circulation: a Presidential Advisory From the American Heart Association; 2024."},{"issue":"10","key":"2552_CR4","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1136\/gutjnl-2016-312975","volume":"66","author":"G Alvarez-Sola","year":"2017","unstructured":"Alvarez-Sola G, Uriarte I, Latasa MU, Fernandez-Barrena MG, Urtasun R, Elizalde M, et al. Fibroblast growth factor 15\/19 (FGF15\/19) protects from diet-induced hepatic steatosis: development of an FGF19-based chimeric molecule to promote fatty liver regeneration. Gut. 2017;66(10):1818\u201328.","journal-title":"Gut"},{"issue":"3","key":"2552_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41569-021-00613-5","volume":"19","author":"A Mehta","year":"2022","unstructured":"Mehta A, Shapiro MD. Apolipoproteins in vascular biology and atherosclerotic disease. Nat Reviews Cardiol. 2022;19(3):168\u201379.","journal-title":"Nat Reviews Cardiol"},{"issue":"7","key":"2552_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/CIRCULATIONAHA.119.041149","volume":"140","author":"C Welsh","year":"2019","unstructured":"Welsh C, Celis-Morales CA, Brown R, Mackay DF, Lewsey J, Mark PB, et al. Comparison of conventional lipoprotein tests and apolipoproteins in the prediction of cardiovascular disease. Circulation. 2019;140(7):542\u201352.","journal-title":"Circulation"},{"issue":"9","key":"2552_CR7","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1093\/eurjpc\/zwae080","volume":"31","author":"J Zhang","year":"2024","unstructured":"Zhang J, Song X, Li Z, Xu H, Shu H, Li J, Zhang Y. Association of apolipoprotein levels with all-cause and cardiovascular mortality. Eur J Prev Cardiol. 2024;31(9):1183\u201394.","journal-title":"Eur J Prev Cardiol"},{"issue":"6","key":"2552_CR8","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1161\/STROKEAHA.123.044424","volume":"55","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wang W, Cui X, Lyu J, Xie Y. Exploring genetic associations of 3 types of risk factors with ischemic stroke: an integrated bioinformatics study. Stroke. 2024;55(6):1619\u201328.","journal-title":"Stroke"},{"issue":"17","key":"2552_CR9","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1016\/j.jacc.2019.01.073","volume":"73","author":"P Natarajan","year":"2019","unstructured":"Natarajan P, Collier TS, Jin Z, Lyass A, Li Y, Ibrahim NE, et al. Association of an HDL apolipoproteomic score with coronary atherosclerosis and cardiovascular death. J Am Coll Cardiol. 2019;73(17):2135\u201345.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2552_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12020-021-02961-1","volume":"76","author":"T Yang","year":"2022","unstructured":"Yang T, Zhao B, Pei D. Relationship between the ApoB\/ApoA-I ratio trajectory and risk of type 2 diabetes in China: a retrospective cohort study. Endocrine. 2022;76(1):36\u201343.","journal-title":"Endocrine"},{"issue":"8","key":"2552_CR11","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S0895-4356(00)00198-0","volume":"53","author":"Y Lee","year":"2000","unstructured":"Lee Y, Lin RS, Sung FC, Yang C, Chien K, Chen W, et al. Chin-Shan community cardiovascular cohort in Taiwan-baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol. 2000;53(8):838\u201346.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"2552_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1161\/hs0102.101626","volume":"33","author":"KL Chien","year":"2002","unstructured":"Chien KL, Sung FC, Hsu HC, Su TC, Lin RS, Lee YT. Apolipoprotein A-I and B and stroke events in a community-based cohort in Taiwan: report of the Chin-Shan community cardiovascular study. Stroke. 2002;33(1):39\u201344.","journal-title":"Stroke"},{"issue":"3","key":"2552_CR13","first-page":"226","volume":"33","author":"KL Chien","year":"2017","unstructured":"Chien KL. Mini-review of the Chin-Shan community cardiovascular cohort study in population health research in Taiwan. Acta Cardiol Sin. 2017;33(3):226\u201332.","journal-title":"Acta Cardiol Sin"},{"issue":"1","key":"2552_CR14","doi-asserted-by":"publisher","first-page":"19298","DOI":"10.1038\/s41598-019-55686-7","volume":"9","author":"W-S Yang","year":"2019","unstructured":"Yang W-S, Chen Y-Y, Chen P-C, Hsu H-C, Su T-C, Lin H-J, et al. Association between plasma N-6 polyunsaturated fatty acids levels and the risk of cardiovascular disease in a community-based cohort study. Sci Rep. 2019;9(1):19298.","journal-title":"Sci Rep"},{"issue":"28","key":"2552_CR15","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1200\/JCO.23.02643","volume":"42","author":"JA Schmidt","year":"2024","unstructured":"Schmidt JA, Woolpert KM, Hjorth CF, Farkas DK, Ejlertsen B, Cronin-Fenton D. Social characteristics and adherence to adjuvant endocrine therapy in premenopausal women with breast cancer. J Clin Oncol. 2024;42(28):3300\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2552_CR16","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S2215-0366(24)00038-5","volume":"11","author":"M Senior","year":"2024","unstructured":"Senior M, Pierce M, Taxiarchi VP, Garg S, Edge D, Newlove-Delgado T, et al. 5-year mental health outcomes for children and adolescents presenting with psychiatric symptoms to general practitioners in England: a retrospective cohort study. Lancet Psychiatry. 2024;11(4):274\u201384.","journal-title":"Lancet Psychiatry"},{"key":"2552_CR17","doi-asserted-by":"crossref","unstructured":"Nagin D. Group-based modeling of development. Harvard University Press; 2005.","DOI":"10.4159\/9780674041318"},{"issue":"1","key":"2552_CR18","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1161\/ATVBAHA.123.319742","volume":"44","author":"AB Andraski","year":"2024","unstructured":"Andraski AB, Sacks FM, Aikawa M, Singh SA. Understanding HDL metabolism and biology through in vivo tracer kinetics. Arterioscler Thromb Vasc Biol. 2024;44(1):76\u201388.","journal-title":"Thromb Vascular Biology"},{"issue":"2","key":"2552_CR19","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1161\/ATVBAHA.120.315669","volume":"41","author":"M Busnelli","year":"2021","unstructured":"Busnelli M, Manzini S, Chiara M, Colombo A, Fontana F, Oleari R, et al. Aortic gene expression profiles show how ApoA-I levels modulate inflammation, lysosomal activity, and sphingolipid metabolism in murine atherosclerosis. Arterioscler Thromb Vasc Biol. 2021;41(2):651\u201367.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2552_CR20","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.neubiorev.2021.02.037","volume":"125","author":"G Morris","year":"2021","unstructured":"Morris G, Puri BK, Bortolasci CC, Carvalho A, Berk M, Walder K, et al. The role of high-density lipoprotein cholesterol, apolipoprotein A and paraoxonase-1 in the pathophysiology of neuroprogressive disorders. Neurosci Biobehav Rev. 2021;125:244\u201363.","journal-title":"Neurosci Biobehav Rev"},{"key":"2552_CR21","doi-asserted-by":"crossref","unstructured":"Churchill RA, Gochanour BR, Scott CG, Vasile VC, Rodeheffer RJ, Meeusen JW, Jaffe AS. Association of cardiac biomarkers with long-term cardiovascular events in a community cohort. Biomarkers: Biochemical Indicators of Exposure, Response, and Susceptibility To Chemicals. 2024;29(4):161\u201370.","DOI":"10.1080\/1354750X.2024.2335245"},{"issue":"5","key":"2552_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00392-018-1381-5","volume":"108","author":"MC Bodde","year":"2019","unstructured":"Bodde MC, Hermans MPJ, Jukema JW, Schalij MJ, Lijfering WM, Rosendaal FR, et al. Apolipoproteins A1, B, and apoB\/apoA1 ratio are associated with first ST-segment elevation myocardial infarction but not with recurrent events during long-term follow-up. Clin Res Cardiology: Official J German Cardiac Soc. 2019;108(5):520\u201338.","journal-title":"Clin Res Cardiology: Official J German Cardiac Soc"},{"key":"2552_CR23","doi-asserted-by":"crossref","unstructured":"Akiyama T, Ikegami R, Kubota N, Takano T, Yoneyama S, Okubo T et al. Serum apolipoprotein-A2 levels are a strong predictor of future cardiovascular events in patients undergoing percutaneous coronary intervention. Circulation Journal: Official J Japanese Circulation Soc. 2024;88(11):1770\u20131777.","DOI":"10.1253\/circj.CJ-24-0242"},{"issue":"4","key":"2552_CR24","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1093\/eurjpc\/zwac263","volume":"30","author":"CC Faaborg-Andersen","year":"2023","unstructured":"Faaborg-Andersen CC, Liu C, Subramaniyam V, Desai SR, Sun YV, Wilson PWF, et al. U-shaped relationship between apolipoprotein A1 levels and mortality risk in men and women. Eur J Prev Cardiol. 2023;30(4):293\u2013304.","journal-title":"Eur J Prev Cardiol"},{"key":"2552_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijcard.2018.11.022","volume":"286","author":"P Calabr\u00f2","year":"2019","unstructured":"Calabr\u00f2 P, Niccoli G, Gragnano F, Grove EL, Vergallo R, Mikhailidis DP, et al. Are we ready for a gender-specific approach in interventional cardiology? Int J Cardiol. 2019;286:226\u201333.","journal-title":"Int J Cardiol"},{"issue":"15","key":"2552_CR26","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.jacc.2023.07.018","volume":"82","author":"JR Medina-Inojosa","year":"2023","unstructured":"Medina-Inojosa JR, Somers VK, Garcia M, Thomas RJ, Allison T, Chaudry R, et al. Performance of the ACC\/AHA pooled cohort cardiovascular risk equations in clinical practice. J Am Coll Cardiol. 2023;82(15):1499\u2013508.","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"2552_CR27","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1056\/NEJMoa2400969","volume":"390","author":"CM Gibson","year":"2024","unstructured":"Gibson CM, Duffy D, Korjian S, Bahit MC, Chi G, Alexander JH, et al. Apolipoprotein A1 infusions and cardiovascular outcomes after acute myocardial infarction. N Engl J Med. 2024;390(17):1560\u201371.","journal-title":"N Engl J Med"},{"issue":"9","key":"2552_CR28","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1001\/jamacardio.2018.2121","volume":"3","author":"SJ Nicholls","year":"2018","unstructured":"Nicholls SJ, Andrews J, Kastelein JJP, Merkely B, Nissen SE, Ray KK, et al. Effect of serial infusions of CER-001, a pre-\u03b2 high-density lipoprotein mimetic, on coronary atherosclerosis in patients following acute coronary syndromes in the CER-001 atherosclerosis regression acute coronary syndrome trial: a randomized clinical trial. JAMA Cardiol. 2018;3(9):815\u201322.","journal-title":"JAMA Cardiol"},{"issue":"10","key":"2552_CR29","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/BF03345747","volume":"32","author":"B Violante","year":"2009","unstructured":"Violante B, Gerbaudo L, Borretta G, Tassone F. Effects of extra virgin olive oil supplementation at two different low doses on lipid profile in mild hypercholesterolemic subjects: a randomised clinical trial. J Endocrinol Invest. 2009;32(10):794\u20136.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"2552_CR30","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jnutbio.2014.02.004","volume":"25","author":"J Merino","year":"2014","unstructured":"Merino J, Sala-Vila A, Kones R, Ferre R, Plana N, Girona J, et al. Increasing long-chain n-3PUFA consumption improves small peripheral artery function in patients at intermediate-high cardiovascular risk. J Nutr Biochem. 2014;25(6):642\u20136.","journal-title":"J Nutr Biochem"},{"issue":"3","key":"2552_CR31","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1152\/japplphysiol.01092.2017","volume":"125","author":"M Rosenkilde","year":"2018","unstructured":"Rosenkilde M, Rygaard L, Nordby P, Nielsen LB, Stallknecht B. Exercise and weight loss effects on cardiovascular risk factors in overweight men. J Appl Physiol (1985). 2018;125(3):901\u20138.","journal-title":"J Appl Physiol (1985)"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02552-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02552-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02552-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T09:25:42Z","timestamp":1744277142000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02552-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2552"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02552-3","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the National Taiwan University Hospital Institutional Review Board (IRB No: 201003001R). Written informed consent was obtained from each participant recruited in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The submitted manuscript has been read and approved by all authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"137"}}